Results for tag: "Choroidal Neovascularization Drug"

The Choroidal Neovascularization Drug market is a subset of the Optical Disorders Drugs market. It is composed of drugs used to treat choroidal neovascularization, a condition in which abnormal blood vessels grow beneath the retina. These drugs are used to reduce the growth of these vessels and prevent further damage to the retina. Common treatments include anti-VEGF drugs, photodynamic therapy, and laser photocoagulation. The Choroidal Neovascularization Drug market is highly competitive, with many companies offering treatments for this condition. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, Bayer, and Roche. Other companies such as Genentech, Santen Pharmaceuticals, and Ophthotech are also active in the market. Show Less Read more